Home > Insider Trading > Filing (0001140361-24-047070)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887359	Vericel Corp	VCEL	Biological Products, (No Disgnostic Substances) (2836)	943096597

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1214938	F Kevin Mclaughlin	C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-11-13	7,000	$3.74	18,900	No	4	M	Direct
Common Stock	Disposition	2024-11-13	7,000	$55.54	11,900	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2024-11-13	7,000	$0.00	7,000	$3.74

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,000			No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.
These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.
These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.